Taeyoung to Sack Executives, Cut Employees' Salaries to Save Company 
Spacesuits need a major upgrade for the next phase of exploration 
Snakebites: we thought we’d created a winning new antivenom but then it flopped. Why that turned out to be a good thing 
Narendra Modi’s economy isn’t booming for India’s unemployed youth 
Lotte Wellfood Brings Its Pepero Products to Thailand’s King Power Duty-Free Shop 
Sony Pictures, Apollo Global Reportedly In Talks to Jointly Bid for Paramount 
Genetic diseases: How scientists are working to make DNA repair (almost) a piece of cake 
Type 2 diabetes is not one-size-fits-all: Subtypes affect complications and treatment options 
Samsung Implements Emergency 6-Day Work Week to Combat Slowing Growth 
Food prices will climb everywhere as temperatures rise due to climate change – new research 
Low pay and few contracts make freelance journalism a bleak prospect in 2024 
Be wary of the ‘vibes’: positive investor sentiment doesn’t necessarily match the true value of stocks 
Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study 
Polestar to Launch Polestar 4 Pure EV in South Korea 
How do airplanes fly? An aerospace engineer explains the physics of flight 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
